Preoperative rehabilitation for lung cancer surgery patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial evaluates the effects of a preoperative rehabilitation program at home for patients undergoing lung cancer resection. Participants will be divided into two groups: one receiving only chest physiotherapy and the other receiving both chest physiotherapy and a structured rehabilitation program. The aim is to assess the impact of the rehabilitation on recovery and overall outcomes post-surgery. The study focuses on patients with chronic obstructive pulmonary disease (COPD) who are eligible for lung cancer surgery.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients diagnosed for lung cancer (or highly suspicious for cancer tumor) eligible for resection surgery (lobectomy or pneumonectomy)
* Age \> 18 years
* Presence of Chronic Obstructive Pulmonary Disease (COPD) stages 2-4 of Gold (forced expiratory volume (FEV )/ forced vital capacity (FVC) \<70%, FEV \<80% of predicted) and Exertional dyspnea stage MMRC (Medical Research Council) \> 1
* Patients must provide written consent
* Member of social security scheme

Exclusion Criteria:

* Patients refusing to participate
* COPD stage 1 Gold (VEMS \>= 80% of the theoretical value)
* Presenting an operating contraindication during the initial maximal exercise test
* Presenting cardiac or vascular contraindication to achieve the readaptation program
* Patient living alone at home
* Patient with ventilatory assistance at home (oxygen therapy or noninvasive ventilation (NIV))
* With exercise hypoventilation (PaCO2 \>45 mmHg)
* Cognitive difficulty
* unable major
* pregnancy,
* patients deprived of liberty by a court or administrative decision

Where it's running

• Centre Jean Perrin
  Clermont-Ferrand, France Recruiting
• CHU Clermont Ferrand, Gabriel Montpied, service de médecine du sport et explorations fonctionnelles,
  Clermont-Ferrand, France Not yet recruiting
• Centre de Recherche en Nutrition Humaine
  Clermont-Ferrand, France Not yet recruiting
• CHU Grenoble, Hôpital Michallon
  Grenoble, France Not yet recruiting
• Hospices Civiles de Lyon, groupement hospitalier Est, Hopital Louis Pradel
  Lyon, France Not yet recruiting
• CHU Saint-Etienne, CHU Hopital Nord
  Saint Etienne, France Not yet recruiting

Study contacts

• Principal investigator: Marc FILAIRE, Pr — Centre Jean Perrin
• Study coordinator: Marc FILAIRE, Pr
• Email: marc.filaire@clermont.unicancer.fr
• Phone: 33473278121

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Tumor and genetic features that separate platinum‑resistant ovarian cancer patients from those progression‑free at five years

  This project will test whether clinical, tissue, and genomic features can separate ovarian cancer patients who do not respond to first‑line platinum chemotherapy from those who stay progression‑free for five years.

  Recruiting Centre Jean Perrin · Clermont-Ferrand, PUY DE DOME · NCT07361471

• Circulating DNA to detect leftover disease after chemoradiotherapy for advanced head and neck cancer

  This trial will test whether a blood test for circulating tumor DNA can find leftover cancer three months after chemoradiotherapy in people with locally advanced head and neck squamous cell carcinoma enrolled in Neck-TAR.

  Recruiting at 4 sites Centre Jean Perrin · Aurillac, CANTAL and 3 other locations · NCT07178847

• Using molecular markers to predict treatment response in advanced prostate cancer

  This study is testing if certain markers in tumor DNA can help doctors predict how well a new treatment for advanced prostate cancer will work for patients.

  Recruiting Centre Jean Perrin · Clermont-Ferrand and 4 other locations · NCT06600802

• Identifying new genes linked to hereditary uveal melanoma

  This study is trying to find new genes that might make families more likely to get uveal melanoma, a type of eye cancer, to help improve care and monitoring for those affected.

  Recruiting Centre Jean Perrin · Clermont-Ferrand, Puy-de-Dôme · NCT06550674

• Using augmented reality for tracking during breast cancer surgery

  This study is testing if using augmented reality can help doctors see better during breast cancer surgery to make it less painful and reduce the chances of needing more surgery later.

  Recruiting Centre Jean Perrin · Clermont-Ferrand · NCT06512558

• Detecting residual disease in advanced head and neck cancer using blood samples after radiotherapy

  This study is testing if analyzing blood samples can help find leftover cancer in patients with advanced head and neck cancer after they’ve had radiation treatment.

  Recruiting at 4 sites Centre Jean Perrin · Clermont-Ferrand, Puy-de-Dôme and 3 other locations · NCT05710679

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.